Literature DB >> 23873108

Regulation of BMI1 Polycomb gene expression in histological grades of invasive ductal breast carcinomas and its correlation with hormone receptor status.

M V S Parvathi1, P Balakrishna Murthy, M Vennila, B V Suresh.   

Abstract

BMI1 is the first functional mammalian Polycomb group (PcG) proto-oncogene involved in multiple biological processes. Regulation of B cell-specific Moloney murine leukaemia virus integration site 1 (BMI1) expression with increase in histological grades of breast carcinoma in correlation with hormone receptor status was studied in 60 Indian breast cancer patient's formalin-fixed paraffin-embedded tissue blocks. Relative expression of BMI1 was studied using real-time PCR. Immunohistochemistry explained the distribution of hormone receptor markers. Correlation of BMI1 gene expression with oestrogen receptor, progesterone receptor (PR) and human epidermal growth factor receptor 2/neu status was analysed using Hex-protein docking tool. The hormone receptor expression was reduced with increasing grades of breast tumour. BMI1 gene expression was downregulated (real-time polymerase chain reaction analysis). Docking analysis explained the correlation between BMI1 and PR expression. BMI1 gene was co-regulated (down) with PR in the invasive ductal breast carcinoma with relative progression explicating it a diagnostic biomarker for ductal carcinoma of the breast.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23873108     DOI: 10.1007/s13277-013-0965-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  22 in total

1.  Gene expression profiles of human breast cancer progression.

Authors:  Xiao-Jun Ma; Ranelle Salunga; J Todd Tuggle; Justin Gaudet; Edward Enright; Philip McQuary; Terry Payette; Maria Pistone; Kimberly Stecker; Brian M Zhang; Yi-Xiong Zhou; Heike Varnholt; Barbara Smith; Michelle Gadd; Erica Chatfield; Jessica Kessler; Thomas M Baer; Mark G Erlander; Dennis C Sgroi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-24       Impact factor: 11.205

2.  Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death.

Authors:  L Liu; L G Andrews; T O Tollefsbol
Journal:  Oncogene       Date:  2006-02-27       Impact factor: 9.867

Review 3.  Polycomb silencers control cell fate, development and cancer.

Authors:  Anke Sparmann; Maarten van Lohuizen
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

4.  Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients.

Authors:  Young Jin Choi; Yoon La Choi; Eun Yoon Cho; Young Kee Shin; Ki Woong Sung; Yu Kyeong Hwang; Sang Jin Lee; Gu Kong; Jeong Eon Lee; Jee Soo Kim; Jung Han Kim; Jung-Hyun Yang; Seok Jin Nam
Journal:  Breast Cancer Res Treat       Date:  2008-01-29       Impact factor: 4.872

5.  Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice.

Authors:  Y Haupt; W S Alexander; G Barri; S P Klinken; J M Adams
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

6.  BMI-1 is highly expressed in M0-subtype acute myeloid leukemia.

Authors:  Masashi Sawa; Kazuhito Yamamoto; Toshiya Yokozawa; Hitoshi Kiyoi; Asahi Hishida; Tomohiro Kajiguchi; Masao Seto; Akio Kohno; Kunio Kitamura; Yoshie Itoh; Norio Asou; Nobuyuki Hamajima; Nobuhiko Emi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

Review 7.  Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients.

Authors:  G Gasparini; F Pozza; A L Harris
Journal:  J Natl Cancer Inst       Date:  1993-08-04       Impact factor: 13.506

8.  Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene.

Authors:  N M van der Lugt; J Domen; K Linders; M van Roon; E Robanus-Maandag; H te Riele; M van der Valk; J Deschamps; M Sofroniew; M van Lohuizen
Journal:  Genes Dev       Date:  1994-04-01       Impact factor: 11.361

9.  Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis.

Authors:  Kathy Lee; Gautam Adhikary; Sivaprakasam Balasubramanian; Ramamurthy Gopalakrishnan; Thomas McCormick; Goberdhan P Dimri; Richard L Eckert; Ellen A Rorke
Journal:  J Invest Dermatol       Date:  2007-07-12       Impact factor: 8.551

10.  The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression.

Authors:  S Vonlanthen; J Heighway; H J Altermatt; M Gugger; A Kappeler; M M Borner; M van Lohuizen; D C Betticher
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

View more
  2 in total

1.  Downregulated miR-495 [Corrected] Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer.

Authors:  Lan Wang; Jun-Ling Liu; Liang Yu; Xiang-Xia Liu; Hong-Mei Wu; Fang-Yong Lei; Shu Wu; Xi Wang
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 2.  TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance.

Authors:  Hong Ren; Peizhun Du; Zongyu Ge; Yiting Jin; Di Ding; Xiuping Liu; Qiang Zou
Journal:  J Cancer       Date:  2016-05-25       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.